Sonos Inc
SONOOther · Large accelerated filer · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $1.44B | $1.52B | $1.66B | $1.75B | $645.6M | $175.1M |
| Operating income | −$50.5M | −$48.0M | −$20.5M | $89.5M | $155.0M | −$27.2M |
| Net income | −$61.1M | −$38.1M | −$10.3M | $67.4M | $132.3M | −$52.3M |
| Total assets | $823.3M | $916.3M | $1.00B | $1.19B | $1.14B | $816.1M |
| Total liabilities | $468.1M | $487.7M | $483.6M | $627.9M | $569.8M | $518.2M |
| Equity | $355.2M | $428.6M | $518.7M | $560.5M | $569.0M | $297.8M |
| EPS (diluted) | $-0.51 | $-0.31 | $-0.08 | $0.49 | $1.01 | $-0.48 |
| Shares out. | 120.2M | 121.8M | 125.2M | 126.7M | 127.1M | 112.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −3.5%
- Net margin
- −4.2%
- Return on equity
- −17.2%
- Return on assets
- −7.4%
- Return on capital (ROCE)
- −10.7%
- Liabilities / assets
- 56.9%
- Debt / equity
- 1.32×
- Book value / share
- $2.95
- Revenue growth (YoY)
- −4.9%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 1.15grey zone
- Accruals / assets
- −24.1%clean
- Beneish M-Score
- -3.13normal
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 4 warning● 2 good- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Altman Z″ in the grey zone
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Coliseum Capital Management, LlcPassive (13G)May 15, 2026
- Vanguard Capital Management LlcPassive (13G)Apr 30, 2026
- Vanguard Portfolio Management LlcPassive (13G)Apr 29, 2026
- Vanguard Group IncPassive (13G)Mar 27, 2026
- Blackrock, Inc.Passive (13G)Oct 17, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Lazarus Edward POfficer — Chief Legal Officer | May 15, 2026 | Option exercise | 42,982 | — |
| Casey SaoriOfficer — Chief Financial Officer | May 15, 2026 | Option exercise | 46,565 | — |
| Arabia CarmineDirector | May 6, 2026 | Buy | 50 | $14.49 |
| Coliseum Capital Management, Llc10% owner | Mar 13, 2026 | Buy | 90,000 | $13.20 |
| Coliseum Capital Management, Llc10% owner | Mar 9, 2026 | Buy | 420,000 | $13.95 |
| Genachowski JuliusDirector | Mar 6, 2026 | Gift | 15,427 | $0.00 |
| Mildenhall JonathanDirector | Mar 5, 2026 | Grant | 12,725 | — |
| Kennedy Joseph JudeDirector | Mar 5, 2026 | Grant | 12,725 | — |
| Genachowski JuliusDirector | Mar 5, 2026 | Grant | 12,725 | — |
| Fields Mandy JDirector | Mar 5, 2026 | Grant | 12,725 | — |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 9.4M | 4.4 | -14.4% |
| Apr 30, 2026 | 11.0M | 9.5 | +2.4% |
| Apr 15, 2026 | 10.7M | 10.7 | +8.6% |
| Mar 31, 2026 | 9.9M | 8.0 | -10.8% |
| Mar 13, 2026 | 11.1M | 7.1 | +5.7% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operations · Director / officer changeMay 4, 2026
- Amended charter or bylaws · Shareholder voteMar 11, 2026
- Results of operationsFeb 3, 2026
- Director / officer change · Regulation FD disclosureJan 12, 2026
- Results of operationsNov 5, 2025
- Results of operationsAug 6, 2025
- Director / officer change · Regulation FD disclosureJul 23, 2025
- Results of operationsMay 7, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SDMay 28, 2026
- 4PRIMARY DOCUMENTMay 18, 2026
- 4PRIMARY DOCUMENTMay 18, 2026
- 4PRIMARY DOCUMENTMay 18, 2026
- 4PRIMARY DOCUMENTMay 18, 2026
- SCHEDULE 13G/AMay 15, 2026
- 4PRIMARY DOCUMENTMay 8, 2026
- 3PRIMARY DOCUMENTMay 5, 2026
- 10-QMay 5, 2026
- 8-KMay 4, 2026
- SCHEDULE 13GApr 30, 2026
- SCHEDULE 13GApr 29, 2026
- SCHEDULE 13G/AMar 27, 2026
- 4Mar 17, 2026
- 4Mar 11, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.